Skip to content

Clinical Assessment of Perfusion Techniques During Repair of Coarctation With Aortic Arch Hypoplasia in Infants

Clinical Assessment of Perfusion Techniques During Surgical Repair of Coarctation of Aorta With Aortic Arch Hypoplasia in Infants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02835703
Enrollment
45
Registered
2016-07-18
Start date
2016-07-31
Completion date
2019-08-31
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coarctation of Aorta

Keywords

Congenital heart disease, Coarctation of aorta, Aortic arch hypoplasia, Cerebral selective antegrade perfusion, Double arterial cannulation

Brief summary

The purpose of this study is to evaluate safety and efficacy of three main perfusion methods in surgical repair of coarctation of aorta with aortic arch hypoplasia in infants.

Detailed description

Three perfusion techniques of visceral protection will be assessed - deep hypothermic circulatory arrest, selective antegrade cerebral perfusion and double arterial cannulation (perfusion of brachiocephalic artery with thoracic descending aorta by two arterial cannulas)

Interventions

PROCEDURESurgical repair of coarctation of aorta

Surgical repair of coarctation of aorta with aortic arch hypoplasia under CPB

Sponsors

Meshalkin Research Institute of Pathology of Circulation
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Years
Healthy volunteers
No

Inclusion criteria

* coarctation with severe aortic arch hypoplasia (distal aortic arch z-score \< -2) * coarctation of aorta with septal defects

Exclusion criteria

* coarctation with mild aortic arch hypoplasia (distal aortic arch z-score \> -2) * complex congenital heart diseases including aortic arch hypoplasia (e.g. transposition of great arteries, double oulet right ventricle, atrioventricular septal defect, Shone's complex) * univentricular and duct-dependent heart defects * aortic valve and/or mitral valve stenosis/hypoplasia (aortic valve or mitral valve z-score \< -2.0) * left ventricular dysfunction (left ventricle ejection fraction \< 60%) * congenital renal or central nervous system anomalies * related infectious diseases * prematurity (gestational age \< 37 weeks)

Design outcomes

Primary

MeasureTime frameDescription
Adverse events in early postoperative period30 days after surgeryNumber of participants with adverse events that are related to treatment (including hospital mortality, renal injury (pRIFLE criteria), neurological complications (confirmed by CT or MRI) )

Secondary

MeasureTime frame
Degree of inotropic support (inotropic score)through ICU stay, an average of 3 weeks
Intraoperative blood loss (ml)intraoperatively
Temperature of cooling (C)intraoperatively
Duration of CPB (min)intraoperatively

Countries

Russia

Contacts

Primary ContactYuriy Y Kulyabin, MD
y.y.coolyabin@gmail.com+79538889890

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026